Literature DB >> 9663630

Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.

A A Gleghorn1, G Gee, D Vlahov.   

Abstract

We assessed pharmacists' practices for needle and syringe (NS) sales and their attitudes toward a needle exchange program through a telephone survey of 75 randomly selected pharmacies in Baltimore, Maryland, where possession of drug paraphernalia is illegal but where NS can be purchased without a prescription. Pharmacists' (n=46) procedures for NS sales included asking for picture identification (54%), requiring a prescription (34%), or requiring a diabetic identification (DID, 34%) for NS purchase; multiple responses were allowed. The median number of prescription and nonprescription NS sold per month was 950. Most (86.6%) pharmacists reported selling NS without prescriptions at their discretion. Pharmacists sold a median of 16 nonprescription NS per month. Pharmacists who required prescriptions or DID (56.5%) sold nonprescription NS significantly less often than those who did not require prescriptions or DID (p=.007). Most pharmacists (87%) were aware of the needle exchange program, 78.3% supported the program, and 67.4% supported selling nonprescription NS in pharmacies. Although there was no difference in anticipated effects of needle exchange or in support for needle exchange between pharmacists who did or did not require prescriptions, DID, or both, pharmacists who did require these items were significantly less likely to support pharmacy sales of nonprescription NS than pharmacists with less restrictive sales policies (p=.04). Although most pharmacists surveyed supported access to sterile NS by injection drug users through a needle exchange program, there was a diversity of approaches to nonprescription NS sales among pharmacists in a city that does not require prescriptions for access to sterile NS. Most supported nonpharmacy needle exchange programs, and more than one half limited injection drug users' access to NS through restrictive sales practices. To reduce injection drug users' exposure to HIV, pharmacists should be educated about HIV prevention and injection drug use and be included in development of HIV prevention programs, including legal pharmacy NS sales.

Entities:  

Mesh:

Year:  1998        PMID: 9663630     DOI: 10.1097/00042560-199802001-00016

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  11 in total

1.  Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices.

Authors:  C R Harbke; D G Fisher; H H Cagle; B N Trubatch; A M Fenaughty; M E Johnson
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

2.  New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.

Authors:  B P Linas; P O Coffin; G Backes; D Vlahov
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

3.  Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.

Authors:  Robin A Pollini
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-12

Review 4.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

Review 5.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 6.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

7.  New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.

Authors:  P O Coffin; B P Linas; S H Factor; D Vlahov
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

Review 8.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

9.  Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel.

Authors:  Thomas J Stopka; Richard S Garfein; Alessandra Ross; Steven R Truax
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

10.  A syringe prescription program to prevent infectious disease and improve health of injection drug users.

Authors:  Josiah D Rich; Michelle McKenzie; Grace E Macalino; Lynn E Taylor; Stephanie Sanford-Colby; Francis Wolf; Susan McNamara; Meenakshi Mehrotra; Michael D Stein
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.